The Histiocyte Society is an international network of people that co-ordinate studies of the histiocytoses, which it has divided into Langerhans cell histiocytosis (class I) (previously known as Hand–Schüller–Christian disease and histocytosis-X), non-Langerhans cell histiocytoses (class II), and malignant histiocytosis (class III).[1][2][3][4] They provided the criteria to definitively diagnose Langerhans cell histiocytosis.[5]
- ^ Tebbi, Cameron K. (16 September 2020). Kanwar, Vikramjit S (ed.). "What is the Histiocyte Society classification of histiocytosis syndromes?". Medscape. Retrieved 4 December 2020.
- ^ H. A. Harfi; F. B. Stapleton; H. Nazer (2012). Textbook of Clinical Pediatrics. Springer Science & Business Media. p. 3215. ISBN 978-3-642-02202-9.
- ^ Chang, Karen L.; Snyder, David S. (2007). "17. Langerhans Cell Histiocytosis". In Stephen M. Ansell (ed.). Rare Hematological Malignancies. Springer Science & Business Media. p. 383. ISBN 978-0-387-73743-0.
- ^ Satter, Elizabeth K.; High, Whitney A. (May 2008). "Langerhans cell histiocytosis: a review of the current recommendations of the Histiocyte Society". Pediatric Dermatology. 25 (3): 291–295. doi:10.1111/j.1525-1470.2008.00669.x. ISSN 1525-1470. PMID 18577030. S2CID 20024618.
- ^ Ajithkumar, Thankamma V; Barrett, Ann; Hatcher, Helen; Cook, Natalie (2011). "4. Site specific cancer management". Oxford Desk Reference: Oncology. Oxford University Press. p. 523. ISBN 978-0-19-923563-6.